Generic Name and Formulations:
Ozenoxacin 1%; crm.
Medimetriks Pharmaceuticals, Inc.
Indications for XEPI:
Impetigo due to S. pyogenes or S. aureus.
Adults and Children:
<2mos: not established. ≥2mos: apply thin layer to affected area twice daily for 5 days. May cover with sterile bandage or gauze dressing. Affected area should be 2% of total BSA and max 100cm2 (if <12yrs) or up to 100cm2 (if ≥12yrs). Wash hands after application.
Not for oral, ophthalmic, intranasal, or intravaginal use. Discontinue if superinfection occurs. Pregnancy. Nursing mothers.
Rosacea, seborrheic dermatitis.
Crm—10g, 30g, 45g
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Age of Onset of Bipolar Disorder Linked With Substance Use Disorders
- Rapid Cycling in Bipolar Disorder: Overview and Expert Perspectives
- Low Testosterone Linked With Social Anxiety in Boys With Klinefelter Syndrome
- Posttraumatic Stress Disorder Associated With Reduced Brain Volume
- First-Episode Drug-Naive Patients With Schizophrenia More Likely to Attempt Suicide
- The Psychology of Hoarding Disorder: Approaches for Treatment
- Mind-Body Therapy and Psychiatry: Ancient Tools for Modern Practice
- Smartphone Applications for Depression and Anxiety: Are They Ready for Widespread Use?
- The Many Misconceptions of Catatonia: Treatment Is Often Successful With the Right Knowledge
- Marijuana Use Associated With Poorer Depression Outcomes, Increased Suicidal Ideation
- Healthcare Community Should Favor More Restrictive Alcohol Policies
- How to Respond to a Patient's Request for Prayer: A Clinician's Dilemma
- Major Barriers to Useful Risk Prediction Must Be Overcome to Reach the Full Potential of Big Data
- ACA Coverage Gains Include Workers Without Insurance
- Steps Provided for Discharging Patients From Practice